Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Roederer

Showing results (331-340 of 405) with videos related to

Pageof 41
Sort By:
Journal of Virology|February 10, 2017
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman PrimatesJuan García-Arriaza, Beatriz Perdiguero, Jonathan L Heeney, et al.
Frontiers in Immunology|June 19, 2026
A proteome-wide atlas of humoral immunity to <i>Mycobacterium tuberculosis</i> across the spectrum of diseaseMehak Z Khan, Edward B Irvine, Deniz Cizmeci, et al.
Science Translational Medicine|January 14, 2021
Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8<sup>+</sup> T cells drive gastrointestinal acute graft-versus-host diseaseVictor Tkachev, James Kaminski, E Lake Potter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancerKevin C Conlon, Enrico Lugli, Hugh C Welles, et al.
Research Square|April 24, 2023
Vaccination with intravenous BCG protects macaques with pre-existing SIV infection from tuberculosisErica C Larson, Amy L Ellis-Connell, Mark A Rodgers, et al.
Nature Medicine|October 2, 2023
AZD5582 plus SIV-specific antibodies reduce lymph node viral reservoirs in antiretroviral therapy-suppressed macaquesAmir Dashti, Sophia Sukkestad, Anna M Horner, et al.
Journal of Virology|November 16, 2018
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVACKaren V Kibler, Benedikt Asbach, Beatriz Perdiguero, et al.
Journal of Virology|June 5, 2015
Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman PrimatesJuan García-Arriaza, Beatriz Perdiguero, Jonathan Heeney, et al.
Immunity|June 1, 2022
Phage display of environmental protein toxins and virulence factors reveals the prevalence, persistence, and genetics of antibody responsesJulia W Angkeow, Daniel R Monaco, Athena Chen, et al.
Plos One|April 15, 2016
Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus MacaquesGerard Zurawski, Sandra Zurawski, Anne-Laure Flamar, et al.
Pageof 41

Showing results (331-340 of 405) with videos related to

Sort By:
Pageof 41
Journal of Virology|February 10, 2017
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman PrimatesJuan García-Arriaza, Beatriz Perdiguero, Jonathan L Heeney, et al.
Frontiers in Immunology|June 19, 2026
A proteome-wide atlas of humoral immunity to <i>Mycobacterium tuberculosis</i> across the spectrum of diseaseMehak Z Khan, Edward B Irvine, Deniz Cizmeci, et al.
Science Translational Medicine|January 14, 2021
Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8<sup>+</sup> T cells drive gastrointestinal acute graft-versus-host diseaseVictor Tkachev, James Kaminski, E Lake Potter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancerKevin C Conlon, Enrico Lugli, Hugh C Welles, et al.
Research Square|April 24, 2023
Vaccination with intravenous BCG protects macaques with pre-existing SIV infection from tuberculosisErica C Larson, Amy L Ellis-Connell, Mark A Rodgers, et al.
Nature Medicine|October 2, 2023
AZD5582 plus SIV-specific antibodies reduce lymph node viral reservoirs in antiretroviral therapy-suppressed macaquesAmir Dashti, Sophia Sukkestad, Anna M Horner, et al.
Journal of Virology|November 16, 2018
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVACKaren V Kibler, Benedikt Asbach, Beatriz Perdiguero, et al.
Journal of Virology|June 5, 2015
Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman PrimatesJuan García-Arriaza, Beatriz Perdiguero, Jonathan Heeney, et al.
Immunity|June 1, 2022
Phage display of environmental protein toxins and virulence factors reveals the prevalence, persistence, and genetics of antibody responsesJulia W Angkeow, Daniel R Monaco, Athena Chen, et al.
Plos One|April 15, 2016
Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus MacaquesGerard Zurawski, Sandra Zurawski, Anne-Laure Flamar, et al.
Pageof 41